Iris Mildenberger

688 total citations
28 papers, 358 citations indexed

About

Iris Mildenberger is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Iris Mildenberger has authored 28 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 9 papers in Genetics. Recurrent topics in Iris Mildenberger's work include CAR-T cell therapy research (10 papers), Glioma Diagnosis and Treatment (9 papers) and Immunotherapy and Immune Responses (9 papers). Iris Mildenberger is often cited by papers focused on CAR-T cell therapy research (10 papers), Glioma Diagnosis and Treatment (9 papers) and Immunotherapy and Immune Responses (9 papers). Iris Mildenberger collaborates with scholars based in Germany, United States and France. Iris Mildenberger's co-authors include Michael C. Burger, Jörg Steinbach, Winfried S. Wels, Marlies Wagner, Congcong Zhang, Sarah Oelsner, Sabrina Genßler, Michel Mittelbronn, Michael Platten and Florian Geßler and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Iris Mildenberger

25 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Mildenberger Germany 8 186 167 124 62 31 28 358
Andrea Gras Navarro Norway 10 198 1.1× 252 1.5× 108 0.9× 79 1.3× 23 0.7× 16 405
Anik L. Côté United States 8 229 1.2× 255 1.5× 87 0.7× 70 1.1× 29 0.9× 8 393
Valentina Robila United States 10 129 0.7× 141 0.8× 153 1.2× 38 0.6× 21 0.7× 25 359
Denise Lally-Goss United States 6 173 0.9× 176 1.1× 73 0.6× 173 2.8× 29 0.9× 13 327
Ahmed Belal United States 7 156 0.8× 189 1.1× 107 0.9× 149 2.4× 39 1.3× 19 327
Brian M. Andersen United States 10 127 0.7× 240 1.4× 116 0.9× 119 1.9× 44 1.4× 10 385
Pia Sommerkamp Germany 7 95 0.5× 242 1.4× 141 1.1× 63 1.0× 30 1.0× 14 394
Cristina Corbetta Italy 6 150 0.8× 128 0.8× 118 1.0× 144 2.3× 53 1.7× 9 351
Leonel Ampie United States 10 206 1.1× 227 1.4× 122 1.0× 174 2.8× 31 1.0× 15 479
Oliver Hill Germany 11 134 0.7× 207 1.2× 235 1.9× 18 0.3× 34 1.1× 15 419

Countries citing papers authored by Iris Mildenberger

Since Specialization
Citations

This map shows the geographic impact of Iris Mildenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Mildenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Mildenberger more than expected).

Fields of papers citing papers by Iris Mildenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Mildenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Mildenberger. The network helps show where Iris Mildenberger may publish in the future.

Co-authorship network of co-authors of Iris Mildenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Mildenberger. A scholar is included among the top collaborators of Iris Mildenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Mildenberger. Iris Mildenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Straßheimer, F, Jadranka Macas, Tijna Alekseeva, et al.. (2025). CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. British Journal of Cancer. 132(9). 849–860. 6 indexed citations
2.
Wick, Wolfgang, Antje Wick, Inga Harting, et al.. (2024). CTNI-85. FINAL RESULTS FROM N2M2/NOA-20. Neuro-Oncology. 26(Supplement_8). viii117–viii117.
3.
Lindner, Katharina A.M., Chin Leng Tan, Kristine Jähne, et al.. (2024). H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient. Science Advances. 10(5). eadi9091–eadi9091. 7 indexed citations
4.
Tabatabai, Ghazaleh, Louisa von Baumgarten, Martin J. van den Bent, et al.. (2024). Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.. Journal of Clinical Oncology. 42(16_suppl). TPS2095–TPS2095. 3 indexed citations
5.
6.
Keßler, Tobias, Philipp Eisele, Miriam Ratliff, et al.. (2023). Concurrent gliomas in patients with multiple sclerosis. SHILAP Revista de lepidopterología. 3(1). 186–186. 1 indexed citations
7.
Mildenberger, Iris, Lukas Bunse, Felix Sahm, et al.. (2023). P02.07.A IMMUNOLOGICAL AND EPIGENETIC FEATURES OF RADIATION NECROSIS IN GLIOBLASTOMA PATIENTS. Neuro-Oncology. 25(Supplement_2). ii30–ii31.
8.
Fastner, Christian, Iris Mildenberger, Svetlana Hetjens, et al.. (2022). Coronary Artery Disease in Patients Presenting With Acute Ischemic Stroke or Transient Ischemic Attack and Elevated Troponin Levels. Frontiers in Neurology. 12. 781553–781553. 7 indexed citations
9.
Reardon, David A., Ahmed Idbaïh, María Vieito, et al.. (2022). CTIM-17. EO2401 THERAPEUTIC VACCINE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA: PHASE 1/2 ROSALIE STUDY (NCT04116658). Neuro-Oncology. 24(Supplement_7). vii63–vii63. 3 indexed citations
10.
Reardon, David A., Ahmed Idbaïh, María Vieito, et al.. (2022). 642 EO2401 microbiome derived therapeutic vaccine + nivolumab, with/without standard continuous, or low-dose symptom directed, bevacizumab, in recurrent glioblastoma: phase 1–2 EOGBM1–18/ROSALIE study. Regular and Young Investigator Award Abstracts. A673–A673. 3 indexed citations
11.
Friedrich, Mirco, Katharina A.M. Lindner, Iris Mildenberger, et al.. (2021). Intrathecal activation of CD8 + memory T cells in IgG4‐related disease of the brain parenchyma. EMBO Molecular Medicine. 13(8). e13953–e13953. 8 indexed citations
12.
Luger, Anna‐Luisa, Iris Mildenberger, Alberto Delaidelli, et al.. (2020). AMPK activation protects astrocytes from hypoxia‑induced cell death. International Journal of Molecular Medicine. 45(5). 1385–1396. 14 indexed citations
13.
Mildenberger, Iris, Philipp Eisele, Ralf‐Dieter Hofheinz, & Michael Platten. (2019). Therapieassoziierte neurologische Symptome onkologischer Patienten und deren Behandlung. Der Nervenarzt. 90(6). 587–593. 1 indexed citations
14.
Lanz, Tobias V., Anne‐Katrin Pröbstel, Iris Mildenberger, Michael Platten, & Lucas Schirmer. (2019). Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and Diagnostics. Frontiers in Immunology. 10. 1302–1302. 12 indexed citations
15.
16.
Förster, Alex, Stefanie Brehmer, Marcel Seiz‐Rosenhagen, et al.. (2018). Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI. Journal of Neuro-Oncology. 142(1). 103–109. 4 indexed citations
17.
Burger, Michael C., Iris Mildenberger, Marlies Wagner, et al.. (2017). Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern. International Journal of Molecular Sciences. 18(4). 726–726. 6 indexed citations
18.
Linder, Benedikt, Stephanie Hehlgans, Iris Mildenberger, et al.. (2016). Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic–Induced Apoptosis. Molecular Cancer Therapeutics. 16(1). 156–168. 64 indexed citations
19.
Genßler, Sabrina, Michael C. Burger, Congcong Zhang, et al.. (2015). Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival. OncoImmunology. 5(4). e1119354–e1119354. 155 indexed citations
20.
Rothe, Gunter M., et al.. (1983). Evidence for an intra- and extraplastidic pre-chorismate pathway. Planta. 157(4). 358–366. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Gras Navarro Breakdown of academic impact, for papers by Anik L. Côté Breakdown of academic impact, for papers by Valentina Robila Breakdown of academic impact, for papers by Denise Lally-Goss Breakdown of academic impact, for papers by Ahmed Belal Breakdown of academic impact, for papers by Brian M. Andersen Breakdown of academic impact, for papers by Pia Sommerkamp Breakdown of academic impact, for papers by Cristina Corbetta Breakdown of academic impact, for papers by Leonel Ampie Breakdown of academic impact, for papers by Oliver Hill
Rankless by CCL
2026